Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04729608
What this trial is testing

Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Aravive, Inc. 366
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02092363
What this trial is testing

Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer

Who this might be right for
Ovarian Cancer
OncoMed Pharmaceuticals, Inc. 37
Early research (Phase 1)Study completedNCT00228358
What this trial is testing

Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerRecurrent Non-small Cell Lung Cancer+6 more
University of Washington 8
Large-scale testing (Phase 3)Active Not RecruitingNCT05445778
What this trial is testing

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
AbbVie 520
Testing effectiveness (Phase 2)Study completedNCT01481701
What this trial is testing

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Who this might be right for
Ovarian CarcinomaRelapse
Jules Bordet Institute 90
Not applicableLooking for participantsNCT06459271
What this trial is testing

Feasibility of CALM in Patients With Ovarian Cancer

Who this might be right for
Patient SatisfactionOvarian Cancer
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05296512
What this trial is testing

Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer

Who this might be right for
Ovarian Clear Cell CarcinomaGynecologic Cancer
Elizabeth K. Lee MD 30
Testing effectiveness (Phase 2)WithdrawnNCT00006267
What this trial is testing

Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00002600
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Testing effectiveness (Phase 2)Looking for participantsNCT05990192
What this trial is testing

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy

Who this might be right for
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom 42
Testing effectiveness (Phase 2)Study completedNCT01358071
What this trial is testing

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
AGC Biologics S.p.A. 119
Testing effectiveness (Phase 2)Study completedNCT01381861
What this trial is testing

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Tracon Pharmaceuticals Inc. 23
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Not applicableLooking for participantsNCT06988280
What this trial is testing

Ultrasound-guided Transvaginal Aspiration of Cystic Pelvic Lesions

Who this might be right for
Pelvic AbscessAdnexal CystOvarian Neoplasms
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06494150
What this trial is testing

Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)

Who this might be right for
Low Grade Ovarian Serous Adenocarcinoma
University of Oklahoma 37
Testing effectiveness (Phase 2)Study completedNCT01105650
What this trial is testing

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Ended earlyNCT01821859
What this trial is testing

Abraxane/Bevacizumab

Who this might be right for
Ovarian CancerPeritoneal Cancer
OHSU Knight Cancer Institute 5
Early research (Phase 1)WithdrawnNCT02470559
What this trial is testing

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Who this might be right for
Malignant Ovarian Clear Cell TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube Carcinoma+14 more
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00721162
What this trial is testing

Study of Ramucirumab in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Eli Lilly and Company 60
Next Page